摘要:
The present disclosure provides methods for inducing somatic cells to form induced pluripotent stem (iPS) cells. The method includes introducing a small activating RNA (saRNA) molecule into the somatic cell, where the saRNA molecule increases transcription of a transcription factor that induces the formation of induced pluripotent stem cells. The present disclosure also provides compositions and kits comprising a saRNA molecule that increases transcription of a transcription factor that induces the formation of induced pluripotent stem cells. The present disclosure provides iPS cells comprising at least one exogenous saRNA molecule, where the saRNA molecule increases transcription of a transcription factor that induces the formation of induced pluripotent stem cells.
摘要:
The present disclosure provides compositions, pharmaceutical preparations, kits and methods for increasing expression of a NKX3-1 gene product in a cell by contacting the cell with a small activating RNA (saRNA) molecule comprising a ribonucleic strand that is complementary to a promoter region sequence of the NKX3-1 gene. The present disclosure also provides compositions, pharmaceutical preparations, kits and methods for increasing expression of a KLF4 gene product in a cell by contacting the cell with a small activating RNA (saRNA) molecule comprising a ribonucleic strand that is complementary to a promoter region sequence of the KLF4 gene.
摘要翻译:本公开提供了通过使细胞与包含与启动子区序列互补的核糖核苷酸的小激活RNA(saRNA)分子来增加NKX3-1基因产物在细胞中的表达的组合物,药物制剂,试剂盒和方法 的NKX3-1基因。 本公开还提供了通过使细胞与包含核苷酸链的小激活RNA(saRNA)分子接触来增加细胞中KLF4基因产物的表达的组合物,药物制剂,试剂盒和方法,所述核糖核酸链与SEQ ID NO: KLF4基因。
摘要:
The present disclosure provides compositions, pharmaceutical preparations, kits and methods for increasing expression of a NKX3-1 gene product in a cell by contacting the cell with a small activating RNA (saRNA) molecule comprising a ribonucleic strand that is complementary to a promoter region sequence of the NKX3-1 gene. The present disclosure also provides compositions, pharmaceutical preparations, kits and methods for increasing expression of a KLF4 gene product in a cell by contacting the cell with a small activating RNA (saRNA) molecule comprising a ribonucleic strand that is complementary to a promoter region sequence of the KLF4 gene.
摘要翻译:本公开提供了通过使细胞与包含与启动子区序列互补的核糖核苷酸的小激活RNA(saRNA)分子来增加NKX3-1基因产物在细胞中的表达的组合物,药物制剂,试剂盒和方法 的NKX3-1基因。 本公开还提供了通过使细胞与包含核苷酸链的小激活RNA(saRNA)分子接触来增加细胞中KLF4基因产物的表达的组合物,药物制剂,试剂盒和方法,所述核糖核酸链与SEQ ID NO: KLF4基因。
摘要:
Methods, compositions and kits are provided for increasing the expression of a gene product in a cell by contacting the cell with a modified small activating RNA (saRNA) molecule, which provides for an increase in gene expression that is improved over the increase in expression provided by traditional saRNAs. These methods and compositions find use in any application in which an increase in gene expression in a cell is desired.
摘要:
Methods, compositions and kits are provided for increasing the expression of a gene product in a cell by contacting the cell with a modified small activating RNA (saRNA) molecule, which provides for an increase in gene expression that is improved over the increase in expression provided by traditional saRNAs. These methods and compositions find use in any application in which an increase in gene expression in a cell is desired.
摘要:
The present invention provides compositions, pharmaceutical preparations, kits and methods for increasing expression of a gene product in a cell by contacting the cell with a microRNA (miRNA) molecule comprising a ribonucleic strand that is complementary to a non-coding nucleic acid sequence of the gene.